Bio-effect of nanoparticles in the cardiovascular system

Journal of Biomedical Materials Research - Part A

Volumn 104, Issue 11, 2016, Pages 2881-2897

  Yu, Xiaohong ^a   Hong, Fashui ^b   Zhang, Yu Qing ^a  

^a SOOCHOW UNIVERSITY   (China)

^b HUAIYIN NORMAL UNIVERSITY   (China)

Author keywords

bio toxicity; cardiovascular system; medical application; nanoparticles; toxic mechanism

Indexed keywords

CARBON BLACK; CARBON NANOTUBES; CARDIOVASCULAR SYSTEM; II-VI SEMICONDUCTORS; MEDICAL APPLICATIONS; SILICA; TITANIUM OXIDES; YARN; ZINC OXIDE;

BIO-EFFECTS; COMPREHENSIVE EVALUATION; CV SYSTEMS; HEALTH AND SAFETY; HUMAN EXPOSURES; IN-VITRO; PHYSICOCHEMICAL PROPERTY; RISK EVALUATION;

NANOPARTICLES;

ANTIFUNGAL AGENT; BLACK CARBON NANOPARTICLE; CARBON NANOTUBE PARTICLE; CONTRAST MEDIUM; ION CHANNEL; NANOPARTICLE; SILICA NANOPARTICLE; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE; TITANIUM DIOXIDE NANOPARTICLE; UNCLASSIFIED DRUG; ZINC OXIDE NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CARDIOTOXICITY; CARDIOVASCULAR SYSTEM; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EVALUATION STUDY; EXPOSURE; GENE THERAPY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRACELLULAR SIGNALING; MOLECULAR IMAGING; NANOMEDICINE; NANOTECHNOLOGY; NERVOUS SYSTEM; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVIEW;

EID: 84988911173     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35804     Document Type: Review

References (157)

1. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005;113:823–839.
2. Donaldson K. Resolving the nanoparticles paradox. Nanomedicine 2006;1:229–234.
3. Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW. Nanoparticles: Pharmacological and toxicological significance. Br J Pharmacol 2007;150:552–558.
4. Linkov I, Satterstrom FK, Corey LM. Nanotoxicology and nanomedicine: Making hard decisions. Nanomedicine 2008;4:167–171.
5. Skocaj M, Filipic M, Petkovic J, Novak S. Titanium dioxide in our everyday life; is it safe? Radiol Oncol 2011;45:227–247.
6. Kaida T, Kobayashi K, Adachi M, Suzuki F. Optical characteristics of titanium oxide interference film and the film laminated with oxides and their applications for cosmetics. J Cosmet Sci 2004;55:219–220.
7. Weir A, Westerhoff P, Fabricius L, Hristovski K, von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ Sci Technol 2012;46:2242–2250.
8. Ling MP, Chio CP, Chou WC, Chen WY, Hsieh NH, Lin YJ, Liao CM. Assessing the potential exposure risk and control for airborne titanium dioxide and carbon black nanoparticles in the workplace. Environ Sci Pollut Res Int 2011;18:877–889.
9. Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 2001;103:2810–2815.
10. Araujo JA, Nel AE. Particulate matter and atherosclerosis: Role of particle size, composition and oxidative stress. Part Fibre Toxicol 2009;6:24
11. Simkhovich BZ, Kleinman MT, Kloner RA. Particulate air pollution and coronary heart disease. Curr Opin Cardiol 2009;24:604–609.
12. Møller P, Mikkelsen L, Vesterdal LK, Folkmann JK, Forchhammer L, Roursgaard M, Danielsen PH, Loft S. Hazard identification of particulate matter on vasomotor dysfunction and progression of atherosclerosis. Crit Rev Toxicol 2011;41:339–368.
13. Vlasova MA, Tarasova OS, Riikonen J, Raula J, Lobach AS, Borzykh AA, Smirin BV, Kauppinen EI, Eletskii AV, Herzig KH, Salonen J, Tavi P, Lehto VP, Järvinen K. Injected nanoparticles: The combination of experimental systems to assess cardiovascular adverse effects. Eur J Pharm Biopharm 2014;87:64–72.
14. Stampfl A, Maier M, Radykewicz R, Reitmeir P, Göttlicher M, Niessner R. Langendorff heart: A model system to study cardiovascular effects of engineered nanoparticles. ACS Nano 2011;5:5345–5353.
15. Murthy SK. Nanoparticles in modern medicine: State of the art and future challenges. In J Nanomed 2007;2:129–141.
16. Szelenyi I. Nanomedicine: Evolutionary and revolutionary developments in the treatment of certain inflammatory diseases. Inflamm Res 2012;61:1–9.
17. Sha BY, Gao W, Wang SQ, Li W, Liang X, Xu F, Lu TJ. Nano-titanium dioxide induced cardiac injury in rat under oxidative stress. Food Chem Toxicol 2013;58:280–288.
18. Sheng L, Wang X, Sang X, Ze Y, Zhao X, Liu D, Gui S, Sun Q, Cheng J, Cheng Z, Hu R, Wang L, Hong F. Cardiac oxidative damage in mice following exposure to nanoparticulate titanium dioxide. J Biomed Mater Res A 2013;101:3238−3246.
19. Hong FS, Wang L, Yu XH, Zhou YJ, Hong J. Toxicological effect of TiO2 nanoparticle-induced myocarditis in mice. Nanoscale Res Lett 2015;10:326
20. Husain M, Wu D, Saber AT, Decan N, Jacobsen NR, Williams A, Yauk CL, Wallin H, Vogel U, Halappanavar S. Intratracheally instilled titanium dioxide nanoparticles translocate to heart and liver and activate complement cascade in the heart of C57BL/6 mice. Nanotoxicology 2015;20:1–10.
21. Nurkiewicz TR, Porter DW, Hubbs AF, Cumpston JL, Chen BT, Frazer DG, Castranova V. Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction. Part Fibre Toxicol 2008;5:1
22. LeBlanc AJ, Cumpston JL, Chen BT, Frazer D, Castranova V, Nurkiewicz TR. Nanoparticle inhalation impairs endothelium-dependent vasodilation in subepicardial arterioles. J Toxicol Environ Health A 2009;72:1576–1584.
23. Knuckles TL, Yi J, Frazer DG, Leonard HD, Chen BT, Castranova V, Nurkiewicz TR. Nanoparticle inhalation alters systemic arteriolar vasoreactivity through sympathetic and cyclooxygenase-mediated pathways. Nanotoxicology 2012;6:724–735.
24. LeBlanc AJ, Moseley AM, Chen BT, Frazer D, Castranova V, Nurkiewicz TR. Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen species-dependent mechanism. Cardiovasc Toxicol 2010;10:27–36.
25. Nurkiewicz TR, Porter DW, Hubbs AF, Stone S, Moseley AM, Cumpston JL, Goodwill AG, Frisbee SJ, Perrotta PL, Brock RW, Frisbee JC, Boegehold MA, Frazer DG, Chen BT, Castranova V. HEI Health Review Committee. Pulmonary particulate matter and systemic microvascular dysfunction. Res Rep Health Eff Inst 2011;3–48.
26. Nurkiewicz TR, Porter DW, Hubbs AF, Stone S, Chen BT, Frazer DG, Boegehold MA, Castranova V. Pulmonary nanoparticle exposure disrupts systemic microvascular nitric oxide signaling. Toxicol Sci 2009;110:191–203.
27. Bu Q, Yan G, Deng P, Peng F, Lin H, Xu Y, Cao Z, Zhou T, Xue A, Wang Y, Cen X, Zhao YL. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxidenanoparticles in rats afte r oral administration. Nanotechnology 2010;21:125105
28. Liu H, Ma L, Zhao J, Liu J, Yan J, Ruan J, Hong F. Biochemical toxicity of nano-anatase TiO2 particles in mice. Biol Trace Elem Res 2009;129:170–180.
29. Mikkelsen L, Sheykhzade M, Jensen KA, Saber AT, Jacobsen NR, Vogel U, Wallin H, Loft S, Møller P. Modest effect on plaque progression and vasodilatory function in atherosclerosis-prone mice exposed tonanosized TiO(2). Part Fibre Toxicol 2011;8:32
30. Yu X, Zhao X, Ze Y, Wang L, Liu D, Hong J, Xu B, Lin A, Zhang C, Zhao Y, Li B, Hong F. Changes of serum parameters of TiO2 nanoparticle-induced atherosclerosis in mice. J Hazard Mater 2014;280:364–371.
31. Shumakova AA, Trushina ÉN, Mustaphina OK, Soto SKh, Gmoshinskiĭ IV, Khotimchenko SA. [Influence of titanium dioxide and silica nanoparticles on accumulation and toxicity of lead in experiments with intragastric co-administration]. Vopr Pitan 2014;83:57–63.
32. Savi M, Rossi S, Bocchi L, Gennaccaro L, Cacciani F, Perotti A, Amidani D, Alinovi R, Goldoni M, Aliatis I, Lottici PP, Bersani D, Campanini M, Pinelli S, Petyx M, Frati C, Gervasi A, Urbanek K, Quaini F, Buschini A, Stilli D, Rivetti C, Macchi E, Mutti A, Miragoli M, Zaniboni M. Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue. Part Fibre Toxicol 2014;11:63 9:
33. Chen T, Hu J, Chen C, Pu J, Cui X, Jia G. Cardiovascular effects of pulmonary exposure to titanium dioxide nanoparticles in ApoE knockout mice. J Nanosci Nanotechnol 2013;13:3214–3222.
34. Helfenstein M, Miragoli M, Rohr S, Müller L, Wick P, Mohr M, Gehr P, Rothen-Rutishauser B. Effects of combustion-derived ultrafine particles and manufactured nanoparticles on heart cells in vitro. Toxicology 2008;253:70–78.
35. Mallik A, Bryan S, Puukila S, Chen A, Khaper N. Efficacy of Pt-modified TiO(2) nanoparticles in cardiac cells. Exp Clin Cardiol 2011;16:6–10.
36. Strobel C, Torrano AA, Herrmann R, Malissek M, Bräuchle C, Reller A, Treuel L, Hilger I. Effects of the physicochemical properties of titanium dioxide nanoparticles, commonly used as sun protection agents, on microvascular endothelial cells. J Nanopart Res 2014;16:2130
37. Kan H, Wu Z, Young SH, Chen TH, Cumpston JL, Chen F, Kashon ML, Castranova V. Pulmonary exposure of rats to ultrafine titanium dioxide enhances cardiac protein phosphorylation and substance P synthesis in nodose ganglia. Nanotoxicology 2012;6:736–745.
38. Han SG, Newsome B, Hennig B. Titanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells. Toxicology 2013;306:1–8.
39. Chen J, Dong X, Xin Y, Zhao M. Effects of titanium dioxide nano-particles on growth and some histological parameters of zebrafish (Danio rerio) after a long-term exposure. Aquat Toxicol 2011;101:493–499.
40. He X, Aker WG, Hwang HM. An in vivo study on the photo-enhanced toxicities of S-doped TiO2 nanoparticles to zebrafish embryos (Danio rerio) in terms of malformation, mortality, rheotaxis dysfunction, and DNA damage. Nanotoxicology 2014;8:185–195.
41. Jawad H, Boccaccini AR, Ali NN, Harding SE. Assessment of cellular toxicity of TiO2 nanoparticles for cardiac tissue engineering applications. Nanotoxicology 2011;5:372–380.
42. Duan Y, Liu H, Zhao J, Liu C, Li Z, Yan J, Ma L, Liu J, Xie Y, Ruan J, Hong F. The effects of nano-anatase TiO(2) on the activation of lactate dehydrogenase from rat heart. Biol Trace Elem Res 2009;130:162–171.
43. Chen Z, Wang Y, Zhuo L, Chen S, Zhao L, Luan X, Wang H, Jia G. Effect of titanium dioxide nanoparticles on the cardiovascular system after oral administration. Toxicol Lett 2015;239:123–130.
44. Chen Z, Wang Y, Zhuo L, Chen S, Zhao L, Chen T, Li Y, Zhang W, Gao X, Li P, Wang III, Jia G. Interaction of titanium dioxide nanoparticles with glucose on young rats after oral administration. Nanomedicine 2015;11:1633–1642.
45. Montiel-Dávalos A, Ventura-Gallegos JL, Alfaro-Moreno E, Soria-Castro E, García-Latorre E, Cabañas-Moreno JG, del Pilar Ramos-Godinez M, López-Marure R. TiO2 nanoparticles induce dysfunction and activation of human endothelial cells. Chem Res Toxicol 2012;25:920–930.
46. Chen J, Dong X, Zhao J, Tang G. In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J Appl Toxicol 2009;29:330–337.
47. Garza-Ocañas L, Ferrer DA, Burt J, Diaz-Torres LA, Ramírez Cabrera M, Rodríguez VT, Luján Rangel R, Romanovicz D, Jose-Yacaman M. Biodistribution and long-term fate of silver nanoparticles functionalized with bovine serum albumin in rats. Metallomics 2010;2:204–210.
48. Bozhko IV, Minchenko DO, Zinchenko TO, Iavorovskiĭ OP, Minchenko OG. [Effect of silver nanoparticles on the expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-2 mRNA and its alternative splice variants in different rat organs]. Ukr Biokhim Zh 1999;82:68–78.
49. Asharani PV, Lianwu Y, Gong Z, Valiyaveettil S. Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology 2011;5:43–54.
50. Asharani PV, Lian Wu Y, Gong Z, Valiyaveettil S. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 2008;19:255102
51. Park K, Tuttle G, Sinche F, Harper SL. Stability of citrate-capped silver nanoparticles in exposure media and their effects on the development of embryonic zebrafish (Danio rerio). Arch Pharm Res 2013;36:125–133.
52. Cho JG, Kim KT, Ryu TK, Lee JW, Kim JE, Kim J, Lee BC, Jo EH, Yoon J, Eom IC, Choi K, Kim P. Stepwise embryonic toxicity of silver nanoparticles on Oryzias latipes. Biomed Res Int 2013;2013:494671
53. Raieszadeh H, Noaman V, Yadegari M. Echocardiographic assessment of cardiac structural and functional indices in broiler chickens treated with silver nanoparticles. Sci World J 2013;2013:931432
54. Hotowy A, Sawosz E, Pineda L, Sawosz F, Grodzik M, Chwalibog A. Silver nanoparticles administered to chicken affect VEGFA and FGF2 gene expression in breast muscle and heart. Nanosca 2012;7:418
55. Beck I, Hotowy A, Sawosz E, Grodzik M, Wierzbicki M, Kutwin M, Jaworski S, Chwalibog A. Effect of silver nanoparticles and hydroxyproline, administered in ovo, on the development of blood vessels and cartilage collagen structure in chicken embryos. Arch Anim Nutr 2015;69:57–68.
56. Costa CS, Ronconi JV, Daufenbach JF, Gonçalves CL, Rezin GT, Streck EL, Paula MM. In vitro effects of silver nanoparticles on the mitochondrial respiratory chain. Mol Cell Biochem 2010;342:51–56.
57. Wu Y, Zhou Q, Li H, Liu W, Wang T, Jiang G. Effects of silver nanoparticles on the development and histopathology biomarkers of Japanese medaka (Oryzias latipes) using the partial-life test. Aquat Toxicol 2010;100:160–167.
58. Korani M, Rezayat SM, Arbabi Bidgoli S. Sub-chronic dermal toxicity of silver nanoparticles in guinea pig: Special emphasis to heart, bone and kidney toxicities. Iran J Pharm Res 2013;12:511–519.
59. Roberts JR, McKinney W, Kan H, Krajnak K, Frazer DG, Thomas TA, Waugh S, Kenyon A, MacCuspie RI, Hackley VA, Castranova V. Pulmonary and cardiovascular responses of rats to inhalation of silver nanoparticles. J Toxicol Environ Health A 2013;76:651–668.
60. Pryskoka AO. [Study of the effect of colloidal solution of silver nanoparticles on parameters of cardio- and hemo-dynamics in rabbits]. Lik Sprava 2014;146–150.
61. Trickler WJ, Lantz SM, Murdock RC, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Oldenburg SJ, Paule MG, Slikker W, Jr, Hussain SM, Ali SF. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci 2010;118:160–170.
62. Trickler WJ, Lantz-McPeak SM, Robinson BL, Paule MG, Slikker W Jr, Biris AS, Schlager JJ, Hussain SM, Kanungo J, Gonzalez C, Ali SF. Porcine brain microvessel endothelial cells show pro-inflammatory response to the size and composition of metallic nanoparticles. Drug Metab Rev 2014;46:224–231.
63. Rosas-Hernández H, Jiménez-Badillo S, Martínez-Cuevas PP, Gracia-Espino E, Terrones H, Terrones M, Hussain SM, Ali SF, González C. Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicol Lett 2009;191:305–313.
64. Castiglioni S, Caspani C, Cazzaniga A, Maier JA. Short- and long-term effects of silver nanoparticles on human microvascular endothelial cells. World J Biol Chem 2014;5:457–464.
65. Kang K, Lim DH, Choi IH, Kang T, Lee K, Moon EY, Yang Y, Lee MS, Lim JS. Vascular tube formation and angiogenesis induced by polyvinylpyrrolidone-coatedsilver nanoparticles. Toxicol Lett 2011;205:227–234.
66. Gurunathan S, Lee KJ, Kalishwaralal K, Sheikpranbabu S, Vaidyanathan R, Eom SH. Antiangiogenic properties of silver nanoparticles. Biomaterials 2009;30:6341–6350.
67. Kalishwaralal K, Banumathi E, Ram Kumar Pandian S, Deepak V, Muniyandi J, Eom SH, Gurunathan S. Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf B Biointerfaces 2009;73:51–57.
68. Baharara J, Namvar F, Mousavi M, Ramezani T, Mohamad R. Anti-angiogenesis effect of biogenic silver nanoparticles synthesized using saliva officinalis on chick chorioalantoic membrane (CAM). Molecules 2014;19:13498–13508.
69. Krajewski S, Prucek R, Panacek A, Avci-Adali M, Nolte A, Straub A, Zboril R, Wendel HP, Kvitek L. Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human blood. Acta Biomater 2013;9:7460–7468.
70. Shi J, Sun X, Lin Y, Zou X, Li Z, Liao Y, Du M, Zhang H. Endothelial cell injury and dysfunction induced by silver nanoparticles through oxidative stress via IKK/NF-κB pathways. Biomaterials 2014;35:6657–6666.
71. Ashraf JM, Ansari MA, Choi I, Khan HM, Alzohairy MA. Antiglycating potential of gum arabic capped-silver nanoparticles. Appl Biochem Biotechnol 2014;174:398–410.
72. Sheikpranbabu S, Kalishwaralal K, Venkataraman D, Eom SH, Park J, Gurunathan S. Silver nanoparticles inhibit VEGF-and IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells. J Nanobiotechnology 2009;7:8
73. Jun EA, Lim KM, Kim K, Bae ON, Noh JY, Chung KH, Chung JH. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity. Nanotoxicology 2011;5:157–167.
74. Bandyopadhyay D, Baruah H, Gupta B, Sharma S. Silver nano particles prevent platelet adhesion on immobilized fibrinogen. Indian J Clin Biochem 2012;27:164–170.
75. Chen Z, Meng H, Xing G, Yuan H, Zhao F, Liu R, Chang X, Gao X, Wang T, Jia G, Ye C, Chai Z, Zhao Y. Age-related differences in pulmonary and cardiovascular responses to SiO2 nanoparticle inhalation: Nanotoxicity has susceptible population. Environ Sci Technol 2008;42:8985–8992.
76. Duan J, Yu Y, Yu Y, Li Y, Huang P, Zhou X, Peng S, Sun Z. Silica nanoparticles enhance autophagic activity, disturb endothelial cell homeostasis and impair angiogenesis. Part Fibre Toxicol 2014;11:50
77. Duan J, Yu Y, Li Y, Yu Y, Sun Z. Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model. Biomaterials 2013;34:5853–5862.
78. Kasper J, Hermanns MI, Bantz C, Maskos M, Stauber R, Pohl C, Unger RE, Kirkpatrick JC. Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: Comparison with conventional monocultures. Part Fibre Toxicol 2011;8:6
79. Zhang B, Chen L, Choi JJ, Hennig B, Toborek M. Cerebrovascular toxicity of PCB153 is enhanced by binding to silica nanoparticles. J Neuroimmune Pharmacol 2012;7:991–1001.
80. Samuel SP, Jain N, O'Dowd F, Paul T, Kashanin D, Gerard VA, Gun'ko YK, Prina-Mello A, Volkov Y. Multifactorial determinants that govern nanoparticle uptake by human endothelial cells under flow. Int J Nanomed 2012;7:2943–2956.
81. Freese C, Schreiner D, Anspach L, Bantz C, Maskos M, Unger RE, Kirkpatrick CJ. In vitro investigation of silica nanoparticle uptake into human endothelial cells under physiological cyclic stretch. Part Fibre Toxicol 2014;11:68
82. Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW. Amorphous silica nanoparticles aggregate human platelets: Potential implications for vascular homeostasis. Int J Nanomed 2012;7:631–639.
83. Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW. Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: Inflammatory and cytotoxic effects. Int J Nanomed 2011;6:2821–2835.
84. Akbar N, Mohamed T, Whitehead D, Azzawi M. Biocompatibility of amorphous silica nanoparticles: Size and charge effect on vascular function, in vitro. Biotechnol Appl Biochem 2011;58:353–362.
85. Farooq A, Whitehead D, Azzawi M. Attenuation of endothelial-dependent vasodilator responses, induced by dye-encapsulated silica nanoparticles, in aortic vessels. Nanomed (Lond) 2014;9:413–425.
86. Bauer AT, Strozyk EA, Gorzelanny C, Westerhausen C, Desch A, Schneider MF, Schneider SW. Cytotoxicity of silica nanoparticles through exocytosis of von Willebrand factor and necrotic cell death in primary human endothelial cells. Biomaterials 2011;32:8385–8393.
87. Moos PJ, Honeggar M, Malugin A, Herd H, Thiagarajan G, Ghandehari H. Transcriptional responses of human aortic endothelial cells to nanoconstructs used in biomedical applications. Mol Pharm 2013;10:3242–3252.
88. Blechinger J, Bauer AT, Torrano AA, Gorzelanny C, Bräuchle C, Schneider SW. Uptake kinetics and nanotoxicity of silica nanoparticles are cell type dependent. Small 2013;9:3970–80, 3906.
89. Liu X, Sun J. Time-course effects of intravenously administrated silica nanoparticles on blood coagulation and endothelial function in rats. J Nanosci Nanotechnol 2013;13:222–228.
90. Nemmar A, Albarwani S, Beegam S, Yuvaraju P, Yasin J, Attoub S, Ali BH. Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation. Int J Nanomed 2014;9:2779–2789.
91. Santos-Martinez MJ, Tomaszewski KA, Medina C, Bazou D, Gilmer JF, Radomski MW. Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: Comparison with light aggregometry. Int J Nanomed 2015;10:5107–5119.
92. Kim D, Finkenstaedt-Quinn S, Hurley KR, Buchman JT, Haynes CL. On-chip evaluation of platelet adhesion and aggregation upon exposure to mesoporous silica nanoparticles. Analyst 2014;139:906–913.
93. Yoshida T, Yoshioka Y, Tochigi S, Hirai T, Uji M, Ichihashi K, Nagano K, Abe Y, Kamada H, Tsunoda S, Nabeshi H, Higashisaka K, Yoshikawa T, Tsutsumi Y. Intranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in mice. Part Fibre Toxicol 2013;10:41
94. Guidetti GF, Consonni A, Cipolla L, Mustarelli P, Balduini C, Torti M. Nanoparticles induce platelet activation in vitro through stimulation of canonical signalling pathways. Nanomedicine 2012;8:1329–1336.
95. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Arimori A, Isobe M, Tochigi S, Kondoh S, Hirai T, Akase T, Yamashita T, Yamashita K, Yoshida T, Nagano K, Abe Y, Yoshioka Y, Kamada H, Imazawa T, Itoh N, Kondoh M, Yagi K, Mayumi T, Tsunoda S, Tsutsumi Y. Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure. Nanotechnology 2012;23:045101
96. Tavano R, Segat D, Reddi E, Kos J, Rojnik M, Kocbek P, Iratni S, Scheglmann D, Colucci M, Echevarria IM, Selvestrel F, Mancin F, Papini E. Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomed (Lond) 2010;5:881–896.
97. Yamawaki H, Iwai N. Mechanisms underlying nano-sized air-pollution-mediated progression of atherosclerosis: carbon black causes cytotoxic injury/inflammation and inhibits cell growth in vascular endothelial cells. Circ J 2006;70:129–140.
98. Bourdon JA, Saber AT, Jacobsen NR, Williams A, Vogel U, Wallin H, Halappanavar S, Yauk CL. Carbon black nanoparticle intratracheal instillation does not alter cardiac gene expression. Cardiovasc Toxicol 2013;13:406–412.
99. Cao Y, Roursgaard M, Danielsen PH, Møller P, Loft S. Carbon black nanoparticles promote endothelial activation and lipid accumulation in macrophages independently of intracellular ROS production. PLoS One 2014;9:e106711
100. Vesterdal LK, Mikkelsen L, Folkmann JK, Sheykhzade M, Cao Y, Roursgaard M, Loft S, Møller P. Carbon black nanoparticles and vascular dysfunction in cultured endothelial cells and artery segments. Toxicol Lett 2012;214:19–26.
101. Folkmann JK, Vesterdal LK, Sheykhzade M, Loft S, Møller P. Endothelial dysfunction in normal and prediabetic rats with metabolic syndrome exposed by oral gavage to carbon black nanoparticles. Toxicol Sci 2012;129:98–107.
102. Vesterdal LK, Folkmann JK, Jacobsen NR, Sheykhzade M, Wallin H, Loft S, Møller P. Pulmonary exposure to carbon black nanoparticles and vascular effects. Part Fibre Toxicol 2010;7:33
103. Niwa Y, Hiura Y, Murayama T, Yokode M, Iwai N. Nano-sized carbon black exposure exacerbates atherosclerosis in LDL-receptor knockout mice. Circ J 2007;71:1157–1161.
104. Holzer M, Bihari P, Praetner M, Uhl B, Reichel C, Fent J, Vippola M, Lakatos S, Krombach F. Carbon-based nanomaterials accelerate arteriolar thrombus formation in the murine microcirculation independently of their shape. J Appl Toxicol 2014;34:1167–1176.
105. Legramante JM, Valentini F, Magrini A, Palleschi G, Sacco S, Iavicoli I, Pallante M, Moscone D, Galante A, Bergamaschi E, Bergamaschi A, Pietroiusti A. Cardiac autonomic regulation after lung exposure to carbon nanotubes. Hum Exp Toxicol 2009;28:369–375.
106. Nguyen DT, Barham W, Zheng L, Shillinglaw B, Tzou WS, Neltner B, Mestroni L, Bosi S, Ballerini L, Prato M, Sauer WH. Carbon nanotube facilitation of myocardial ablation with radiofrequency energy. J Cardiovasc Electrophysiol 2014;25:1385–1390.
107. Guo YY, Zhang J, Zheng YF, Yang J, Zhu XQ. Cytotoxic and genotoxic effects of multi-wall carbon nanotubes on human umbilical vein endothelial cells in vitro. Mutat Res 2011;721:184–191.
108. Raja PM, Connolley J, Ganesan GP, Ci L, Ajayan PM, Nalamasu O, Thompson DM. Impact of carbon nanotube exposure, dosage and aggregation on smooth muscle cells. Toxicol Lett 2007;169:51–63.
109. Murugesan S, Mousa SA, O'connor LJ, Lincoln DW, Linhardt RJ. Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett 2007;581:1157–1160.
110. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 2005;146:882–893.
111. Bayat N, Lopes VR, Schölermann J, Jensen LD, Cristobal S. Vascular toxicity of ultra-small TiO2 nanoparticles and single walled carbon nanotubes in vitro and in vivo. Biomaterials 2015;63:1–13.
112. Pietroiusti A, Massimiani M, Fenoglio I, Colonna M, Valentini F, Palleschi G, Camaioni A, Magrini A, Siracusa G, Bergamaschi A, Sgambato A, Campagnolo L. Low doses of pristine and oxidized single-wall carbon nanotubes affect mammalian embryonic development. ACS Nano 2011;5:4624–4633.
113. Qi W, Bi J, Zhang X, Wang J, Wang J, Liu P, Li Z, Wu W. Damaging effects of multi-walled carbon nanotubes on pregnant mice with different pregnancy times. Sci Rep 2014;4:4352
114. Ma J, Liu J, Lu CW, Cai DF. Pachymic acid modified carbon nanoparticles reduced angiogenesis via inhibition of MMP-3. Int J Clin Exp Pathol 2015;8:5464–5470.
115. Chaudhuri P, Harfouche R, Soni S, Hentschel DM, Sengupta S. Shape effect of carbon nanovectors on angiogenesis. ACS Nano 2010;4:574–582.
116. Bihari P, Holzer M, Praetner M, Fent J, Lerchenberger M, Reichel CA, Rehberg M, Lakatos S, Krombach F. Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation. Toxicology 2010;269:148–154.
117. Khandoga A, Stoeger T, Khandoga AG, Bihari P, Karg E, Ettehadieh D, Lakatos S, Fent J, Schulz H, Krombach F. Platelet adhesion and fibrinogen deposition in murine microvessels upon inhalation of nanosized carbon particles. J Thromb Haemost 2010;8:1632–1640.
118. Stout DA, Raimondo E, Marostica G, Webster TJ. Growth characteristics of different heart cells on novel nanopatch substrate during electrical stimulation. Biomed Mater Eng 2014;24:2101–217.
119. Yeh TK, Chen JK, Lin CH, Yang MH, Yang CS, Chou FI, Peir JJ, Wang MY, Chang WH, Tsai MH, Tsai HT, Lin P. Kinetics and tissue distribution of neutron-activated zinc oxide nanoparticles and zinc nitrate in mice: Effects of size and particulate nature. Nanotechnology 2012;23:085102
120. Negahdary M, Chelongar R, Zadeh SK, Ajdary M. The antioxidant effects of silver, gold, and zinc oxide nanoparticles on male mice in in vivo condition. Adv Biomed Res 2015;4:69
121. Pasupuleti S, Alapati S, Ganapathy S, Anumolu G, Pully NR, Prakhya BM. Toxicity of zinc oxide nanoparticles through oral route. Toxicol Ind Health 2012;28:675–686.
122. Li CH, Liao PL, Shyu MK, Liu CW, Kao CC, Huang SH, Cheng YW, Kang JJ. Zinc oxide nanoparticles-induced intercellular adhesion molecule 1 expression requires Rac1/Cdc42, mixed lineage kinase 3, and c-Jun N-terminal kinase activation in endothelial cells. Toxicol Sci 2012;126:162–172.
123. Sun J, Wang S, Zhao D, Hun FH, Weng L, Liu H. Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells: Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles. Cell Biol Toxicol 2011;27:333–342.
124. Tsou TC, Yeh SC, Tsai FY, Lin HJ, Cheng TJ, Chao HR, Tai LA. Zinc oxide particles induce inflammatory responses in vascular endothelial cells via NF-κB signaling. J Hazard Mater 2010;183:182–188.
125. Baky NA, Faddah LM, Al-Rasheed NM, Al-Rasheed NM, Fatani AJ. Induction of inflammation, DNA damage and apoptosis in rat heart after oral exposure to zinc oxide nanoparticles and the cardioprotective role of α-lipoic acid and vitamin E. Drug Res (Stuttg) 2013;63:228–236.
126. Kennedy IM, Wilson D, Barakat AI. HEI Health Review Committee. Uptake and inflammatory effects of nanoparticles in a human vascular endothelial cell line. Res Rep Health Eff Inst 2009;3–32.
127. Gojova A, Guo B, Kota RS, Rutledge JC, Kennedy IM, Barakat AI. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition. Environ Health Perspect 2007;115:403–409.
128. Suzuki Y, Tada-Oikawa S, Ichihara G, Yabata M, Izuoka K, Suzuki M, Sakai K, Ichihara S. Zinc oxide nanoparticles induce migration and adhesion of monocytes to endothelial cells and accelerate foam cell formation. Toxicol Appl Pharmacol 2014;278:16–25.
129. Du Z, Zhao D, Jing L, Cui G, Jin M, Li Y, Liu X, Liu Y, Du H, Guo C, Zhou X, Sun Z. Cardiovascular toxicity of different sizes amorphous silica nanoparticles in rats after intratracheal instillation. Cardiovasc Toxicol 2013;13:194–207.
130. Liu X, Sun J. Endothelial cells dysfunction induced by silica nanoparticles through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials 2010;31:8198–8209.
131. Seaton A, Soutar A, Crawford V, Elton R, McNerlan S, Cherrie J, Watt M, Agius R, Stout R. Particulate air pollution and the blood. Thorax 1999;54:1027–1032.
132. Luyts K, Smulders S, Napierska D, Van Kerckhoven S, Poels K, Scheers H, Hemmeryckx B, Nemery B, Hoylaerts MF, Hoet PH. Pulmonary and hemostatic toxicity of multi-walled carbon nanotubes and zinc oxide nanoparticles after pulmonary exposure in Bmal1 knockout mice. Part Fibre Toxicol 2014;11:61
133. Chuang HC, Juan HT, Chang CN, Yan YH, Yuan TH, Wang JS, Chen HC, Hwang YH, Lee CH, Cheng TJ. Cardiopulmonary toxicity of pulmonary exposure to occupationally relevant zinc oxide nanoparticles. Nanotoxicology 2014;8:593–604.
134. Azad N, Iyer AK, Wang L, Liu Y, Lu Y, Rojanasakul Y. Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responses. Nanotoxicology 2013;7:157–168.
135. Bessemer RA, Butler KM, Tunnah L, Callaghan NI, Rundle A, Currie S, Dieni CA, MacCormack TJ. Cardiorespiratory toxicity of environmentally relevant zinc oxide nanoparticles in the freshwater fish Catostomus commersonii. Nanotoxicology 2015;9:861–870.
136. Yang L, Yan Q, Zhao J, Li J, Zong X, Yang L, Wang Z. The role of potassium channel in silica nanoparticle-induced inflammatory effect in human vascular endothelial cells in vitro. Toxicol Lett 2013;223:16–24.
137. Peetla C, Rao KS, Labhasetwar V. Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: Study with TAT peptide-conjugated nanoparticles. Mol Pharm 2009;6:1311–1320.
138. Wu G, Nishikawa T, Ohtani B, Chen A. Synthesis and characterization of carbon-doped TiO2 nanostructures with enhanced visible light response. Chem Mater 2007;19:4530–4537.
139. Paunesku T, Rajh T, Wiederrecht G, et al. Biology of TiO2-oligonucleotide nanocomposites. Nat Mater 2003;2:343–346.
140. Gu Z, Rolfe BE, Thomas AC, Xu ZP. Restenosis treatments using nanoparticle-based drug delivery systems. Curr Pharm Des 2013;19:6330–6339.
141. Mukherjee S, Chowdhury D, Kotcherlakota R, Patra S, B V, Bhadra MP, Sreedhar B, Patra CR. Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system). Theranostics 2014;4:316–335.
142. de Mel A, Chaloupka K, Malam Y, Darbyshire A, Cousins B, Seifalian AM. A silver nanocomposite biomaterial for blood-contacting implants. J Biomed Mater Res A 2012;100:2348–2357.
143. Jackson SN, Baldwin K, Muller L, Womack VM, Schultz JA, Balaban C, Woods AS. Imaging of lipids in rat heart by MALDI-MS with silver nanoparticles. Anal Bioanal Chem 2014;406:1377–1386.
144. Kumar CG, Poornachandra Y. Biodirected synthesis of miconazole-conjugated bacterial silver nanoparticles and their application as antifungal agents and drug delivery vehicles. Colloids Surf B Biointerfaces 2015;125:110–119.
145. Chudobova D, Nejdl L, Gumulec J, Krystofova O, Rodrigo MA, Kynicky J, Ruttkay-Nedecky B, Kopel P, Babula P, Adam V, Kizek R. Complexes of silver(I) ions and silver phosphate nanoparticles with hyaluronic acid and/or chitosan as promising antimicrobial agents for vascular grafts. Int J Mol Sci 2013;14:13592–13614.
146. Yu DG, Lin WC, Yang MC. Surface modification of poly(L-lactic acid) membrane via layer-by-layer assembly of silver nanoparticle-embedded polyelectrolyte multilayer. Bioconjug Chem 2007;18:1521–1529.
147. Galagudza MM, Korolev DV, Sonin DL, Postnov VN, Papayan GV, Uskov IS, Belozertseva AV, Shlyakhto EV. Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: Surface functionalization, natural biodistribution, and acute toxicity. Int J Nanomed 2010;5:231–237.
148. Borak B, Arkowski J, Skrzypiec M, Ziółkowski P, Krajewska B, Wawrzyńska M, Grotthus B, Gliniak H, Szelag A, Mazurek W, Biały D, Maruszewski K. Behavior of silica particles introduced into an isolated rat heart as potential drug carriers. Biomed Mater 2007;2:220–223.
149. Galagudza M, Korolev D, Postnov V, Naumisheva E, Grigorova Y, Uskov I, Shlyakhto E, Int J. Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles. Nanomedicine 2012;7:1671–1678.
150. Lu W, Xie Z, Tang Y, Bai L, Yao Y, Fu C, Ma G. Photoluminescent mesoporous silicon nanoparticles with siCCR2 improve the effects of mesenchymal stromal cell transplantation after acute myocardial infarction. Theranostics 2015;5:1068–1082.
151. Woolley R, Roy S, Prendergast Ú, Panzera A, Basabe-Desmonts L, Kenny D, McDonagh C. From particle to platelet: Optimization of a stable, high brightness fluorescent nanoparticle based cell detection platform. Nanomedicine 2013;9:540–549.
152. Wang Y, Zhang W, Zhang J, Sun W, Zhang R, Gu H. Fabrication of a novel polymer-free nanostructured drug-eluting coating for cardiovascular stents. ACS Appl Mater Interfaces 2013;5:10337–10345.
153. Ruan S, Wan J, Fu Y, Han K, Li X, Chen J, Zhang Q, Shen S, He Q, Gao H. PEGylated fluorescent carbon nanoparticles for noninvasive heart imaging. Bioconjug Chem 2014;25:1061–1068.
154. Cheng J, Gu YJ, Wang Y, Cheng SH, Wong WT. Nanotherapeutics in angiogenesis: Synthesis and in vivo assessment of drug efficacy and biocompatibility in zebrafish embryos. Int J Nanomed 2011;6:2007–2021.
155. Delogu LG, Vidili G, Venturelli E, Ménard-Moyon C, Zoroddu MA, Pilo G, Nicolussi P, Ligios C, Bedognetti D, Sgarrella F, Manetti R, Bianco A. Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. Proc Natl Acad Sci USA 2012;109:16612–16617.
156. Cowles CL, Zhu X. Sensitive detection of cardiac biomarker using ZnS nanoparticles as novel signal transducers. Biosens Bioelectron 2011;30:342–346.
157. Chorny M, Fishbein I, Tengood JE, Adamo RF, Alferiev IS, Levy RJ. Site-specific gene delivery to stented arteries using magnetically guided zinc oleate-based nanoparticles loaded with adenoviral vectors. FASEB J 2013;27:2198–2206.